Mridu Gulati MD
Pleural Disease
Associate Professor, Internal Medicine, Yale University School of Medicine
Join to View Full Profile
6 Devine StNorth Haven, CT 06473
Phone+1 203-495-2410
Fax+1 203-785-3826
Dr. Gulati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Occupational and Environmental Medicine, 2003 - 2005
University of MichiganResidency, Internal Medicine, 1997 - 2000
New York University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2001 - Present
CT State Medical License 2005 - 2026
NY State Medical License 2000 - 2015
MI State Medical License 1997 - 2000
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- 2 citationsProfibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease.Nikolay S Markov, Anthony J Esposito, Karolina J Senkow, Maxwell Schleck, Luisa Cusick
Biorxiv. 2025-10-08 - 7 citationsChanges in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary Fibrosis.Justin M Oldham, Megan L Neely, Daniel M Wojdyla, Mridu Gulati, Peide Li
Chest. 2025-08-01 - 4 citationsLong-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.Coralynn Sack, Daniel M Wojdyla, Maeve G MacMurdo, Amanda Gassett, Joel D Kaufman
Annals of the American Thoracic Society. 2025-03-01
Press Mentions
FSR Expands Scientific Advisory Board to Improve Research, CareSeptember 10th, 2024- Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient CareAugust 28th, 2024
West Hartford Resident Lobbies Legislators to Drive Disease ResearchApril 11th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
